| pubmed-article:17947484 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17947484 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17947484 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:17947484 | lifeskim:mentions | umls-concept:C0221920 | lld:lifeskim |
| pubmed-article:17947484 | lifeskim:mentions | umls-concept:C0149925 | lld:lifeskim |
| pubmed-article:17947484 | lifeskim:mentions | umls-concept:C0376525 | lld:lifeskim |
| pubmed-article:17947484 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:17947484 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:17947484 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
| pubmed-article:17947484 | lifeskim:mentions | umls-concept:C1328025 | lld:lifeskim |
| pubmed-article:17947484 | lifeskim:mentions | umls-concept:C1518422 | lld:lifeskim |
| pubmed-article:17947484 | pubmed:issue | 20 | lld:pubmed |
| pubmed-article:17947484 | pubmed:dateCreated | 2007-10-19 | lld:pubmed |
| pubmed-article:17947484 | pubmed:abstractText | Pertuzumab, a first-in-class human epidermal receptor 2 (HER2) dimerization inhibitor, is a humanized monoclonal anti-HER2 antibody that binds HER2's dimerization domain and inhibits HER2 signaling. Based on supporting preclinical studies, we undertook a Phase II trial of pertuzumab in patients with recurrent non-small cell lung cancer (NSCLC). | lld:pubmed |
| pubmed-article:17947484 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17947484 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17947484 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17947484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17947484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17947484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17947484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17947484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17947484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17947484 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17947484 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17947484 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:17947484 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:SchillerJoan... | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:JohnsonBruce... | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:HerbstRoy SRS | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:MillerVincent... | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:Van den... | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:NataleRonald... | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:EberhardDavid... | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:DaviesAngela... | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:DangThao PTP | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:GarlandLinda... | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:MendelsonDavi... | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:LutzkerStuart... | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:LyonsBenjamin... | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:MelenevskyYul... | lld:pubmed |
| pubmed-article:17947484 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:17947484 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17947484 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:17947484 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:17947484 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17947484 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17947484 | pubmed:pagination | 6175-81 | lld:pubmed |
| pubmed-article:17947484 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:meshHeading | pubmed-meshheading:17947484... | lld:pubmed |
| pubmed-article:17947484 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17947484 | pubmed:articleTitle | Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer. | lld:pubmed |
| pubmed-article:17947484 | pubmed:affiliation | The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. | lld:pubmed |
| pubmed-article:17947484 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17947484 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17947484 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:17947484 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17947484 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17947484 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17947484 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17947484 | lld:pubmed |
